首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   21235篇
  免费   3354篇
  国内免费   3686篇
化学   16972篇
晶体学   370篇
力学   959篇
综合类   262篇
数学   2468篇
物理学   7244篇
  2024年   44篇
  2023年   367篇
  2022年   646篇
  2021年   718篇
  2020年   789篇
  2019年   819篇
  2018年   678篇
  2017年   722篇
  2016年   1017篇
  2015年   1071篇
  2014年   1364篇
  2013年   1725篇
  2012年   1956篇
  2011年   2065篇
  2010年   1497篇
  2009年   1367篇
  2008年   1571篇
  2007年   1384篇
  2006年   1291篇
  2005年   1089篇
  2004年   923篇
  2003年   729篇
  2002年   699篇
  2001年   608篇
  2000年   466篇
  1999年   452篇
  1998年   316篇
  1997年   227篇
  1996年   245篇
  1995年   233篇
  1994年   207篇
  1993年   152篇
  1992年   129篇
  1991年   118篇
  1990年   133篇
  1989年   72篇
  1988年   72篇
  1987年   44篇
  1986年   56篇
  1985年   43篇
  1984年   36篇
  1983年   31篇
  1982年   17篇
  1981年   19篇
  1980年   9篇
  1979年   7篇
  1977年   7篇
  1976年   12篇
  1975年   7篇
  1973年   7篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
891.
A series of tri-substituted chiral pyrrolidin-2-one derivatives have been designed and synthesized as CC chemokine receptor 4 (CCR4) antagonists. The structure of CCR4 was built by homology modeling. Asymmetric synthesis was applied to synthesize the R,R configuration chiral pyrrolidin-2-one scaffold. The stereoisomeric con- figurations of the compounds were identified by 2D I H-~H COSY spectroscopy and 1D NOESY spectroscopy. This method was more economical and convenient than traditional X-ray single crystal diffraction. In addition, the inter- actions between these compounds and the N-terminal extracellular tail of CCR4 were studied using capillary zone electrophoresis. The CCR4 chemotaxis inhibition effect was tested in CCR4-transfected HEK293 cells. Several compounds showed potent activities as CCR4 antagonists. Among these compounds, lc is the most active one. Its apparent binding constant of CZE experiment result is (1.569±0.11)× 10s L·mol ^-1, and its percentage inhibition of the HEK293/CCR4 cells migration with the concentration of I gmol·L ^-1 in DMSO is 59%. And compound If has slightly higher affinity to N-terminal of CCR4 according to its apparent binding constant than lb because of the in- troduced ester linkage. Further studies on the mechanism of these compounds are in progress.  相似文献   
892.
A novel copper selective sensor 2 based on hydrazide and salicylaldehyde has been designed and prepared. Sensor 2 behaves a single selectivity and sensitivity in the recognition for Cu2+ over other metal ions such as Fe3+, Hg2+, Ag+, Ca2+, Zn2+, Pb2+, Cd2+, Ni2+, Co2+, Cr3+ and Mg2+ in DMSO. The distinct color change and the rapid changement of fluorescence emission provide naked‐eyes detection for Cu2+. The UV‐vis data indicate that 1:2 stoichiometry complex is formed by sensor 2 and Cu2+. The association constant Ks was 3.51×104 mol?1·L. The detection limitation of Cu2+ with the sensor 2 was 2.2×10?7 mol·L?1. The sensing of Cu2+ by this sensor was found to be reversible, with the Cu2+‐induced color being lost upon addition of EDTA.  相似文献   
893.
In this paper,we developed and validated a simple,sensitive,and selective high-performance liquid chromatography-tandem mass spectrometry(HPLC-MS/MS) method to identify and measure the following prohibited substances that may be found in cosmetic products:minoxidil,hydrocortisone, spironolactone,estrone,canrenone,triamcinolone acetonide and progesterone.Chromatographic separation was performed on a Waters Symmetry C18(100 mm×2.1 mm,3.5μm particle size) with a gradient elution system composed of 0.2%(v/v) formic acid aqueous solution and methanol containing 0.2%(v/v) formic acid at a flow rate of 0.3 mL/min.The substances were detected using a triple quadrupole mass spectrometer in the multiple reaction monitoring mode with an electrospray ionization source.All of the calibration curves showed good linearity(r > 0.999) within the tested concentration ranges.The limit of detection was <25 pg.The relative standard deviations for intraday precision for each of the prohibited substances were <3.5%at two concentration levels(2μg/g,10μg/g). The relative recovery rate for each of the prohibited substances ranged from 91.8%to 111%at three concentration levels(0.1μg/g,2μg/g,10μg/g),including the limit of quantification.In conclusion,we have developed and validated a method that can identify seven prohibited substances in cosmetic products.  相似文献   
894.
The chiral separations of four pharmaceutical racemates which contain N-alkyl groups were satisfactorily resolved using SBE-β-CD as a chiral mobile phase additive(CMPA)in a RP-HPLC system(the resolution is 2.701 for ondansetron hydrochloride,1.996 for sulpiride,1.293 for clenbuterol hydrochloride and 0.816 for omeprazole).In addition,the effects of different parameters such as CD type and CD concentration were investigated.The separation mechanism arises through the combination of several potential interactions,including electrostatic interactions as well as hydrogen bonding interactions and hydrophobic inclusion interactions,which allow for the SBE-β-CD–drug complexation with strong stereoselectivity and stability.The resolution also relates to the number and location of N atoms in the enantiomers.This method will be applicable to the isolation of various types of biologically important enantiomers containing N-alkyl groups.  相似文献   
895.
Buagafuran is a novel drug candidate derived from natural product.Its absolute configuration has been confirmed by electronic circular dichroism combined with modern quantum-chemical calculation using time-dependent density functional theory.The predicted UV absorbance peak is underestimated by several nanometers compared with the experimental data.The applicability of empirical rule for the C=C-C-O system in Buagafuran has also been discussed.Our results show that electronic circular dichroism could be a useful tool for the absolute configuration assignment of chiral drugs,especially for the oily or semisolid substances,whose crystal structures are impossible to obtain.  相似文献   
896.
Addition of nitroalkanes into n‐alkanes can lower the activation barriers of free‐radical production and accelerate the decomposition of n‐alkanes at relatively low temperatures. Four initial decomposition mechanisms of the n‐butane/nitroethane binary mixture were proposed for the promoting effect and considered theoretically at the B3LYP, BB1K, BMK, MPW1K, and M06‐2X levels with MG3S basis set. Energetics above was compared to high‐level CBS‐QB3 and G4 calculations. Calculated results confirm the feasibility of the four initial decomposition pathways: (I) the C? NO2 bond rupture of nitroethane to produce ethyl and ·NO2, (II) HONO elimination from nitroethane followed by decomposition to ·OH and ·NO, (III) rearrangement of nitroethane to ethyl nitrite which further dissociates into CH3CH2O· and ·NO, and (IV) direct hydrogen‐abstraction of nitroethane with n‐butane.  相似文献   
897.
近年来,钙钛矿太阳能电池由于其效率高、制造成本低、工艺简单等特点受到广泛关注,成为目前太阳能电池领域的研究热点。在钙钛矿太阳能电池中,无机-有机杂化ABX3材料非常重要。它既作为光吸收材料,同时又作为载流子传输材料,因此它的光电性质直接影响到太阳能电池的效率。本文综述了调控钙钛矿型无机有机金属卤化物ABX3结构和性质的几种途径。  相似文献   
898.
通过引入2个不同的氮杂环配体,得到了2个Cd(Ⅱ)配位聚合物[Cd(m-phda)(btbb)0.5]n1)和[Cd(m-phda)(hbmb)0.5]n2)(m-H2phda=间苯二乙酸),并对它们的结构进行了表征。结构分析表明配合物1是一个6-连接的pcu拓扑网络,拓扑符号为412·63。配合物2是一个5-连接的sqp拓扑网络,拓扑符号为(44·66)。另外,配合物12表现出较好的热稳定性和不同的荧光行为。  相似文献   
899.
本论文采用改进的Hummers法制备了氧化石墨烯(GO),并将氧化石墨烯用十二烷基二甲基苄基氯化铵(1227)进行修饰,得到1227非共价改性的氧化石墨烯(GO-1227)。用拉曼光谱、漫反射红外光谱分析、X-射线光电子表面能谱技术表征了其化学结构;用X-射线衍射分析、扫描电子显微镜与透射电子显微镜观察了其剥离情况和微观形貌;分析了它们在不同溶剂中的分散性。结果表明,季铵盐改性后,1227阳离子通过静电作用插入到GO片层之间,使GO片层进一步剥离,且在极性较弱的有机溶剂中的溶解性增加。热失重分析表明,GO-1227的初始分解温度提高了约70℃。将GO-1227与聚甲基丙烯酸甲酯与苯乙烯的嵌段共聚物(PMMA-b-PS)凝胶聚电解质复合,制备了纳米复合凝胶聚合物电解质(NGPE),并用交流阻抗法测试其电性能,发现占聚电解质总质量2‰的GO-1227可以将其离子电导率提高8.6倍。  相似文献   
900.
含巯基/二硫键聚合物生物材料具有多种良好的性能,作为药物、基因等的释放载体在生物医学领域具有广泛的应用前景。随着基因工程和组织工程的发展,含巯基/二硫键聚合物生物材料的可生物降解性得到高度重视,而怎样改善其降解性能成为限制其应用的关键因素。由于二硫键在细胞外环境里保持稳定,在细胞溶质的还原环境中容易发生断裂,因此在制备新型基因、药物等释放载体上,二硫键充当了重要的角色,它的引入为聚合物生物材料的生物降解性能的设计与改善提供了一条重要的途径。本综述重点以聚合物水凝胶、聚合物微胶束、囊泡等为例,从巯基/烯的光聚合反应、Michael加成反应、氧化还原反应的角度,介绍了巯基/烯在聚合物中形成二硫键的不同途径的研究进展,并详细论述了基因载体、蛋白质载体、小分子药物载体三种还原敏感型材料的制备、表面修饰和改性的进展情况,进一步强调含巯基/二硫键聚合物生物材料的研究在生物医学领域应用的重要性。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号